Literature DB >> 11431742

Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.

F Pessione1, M J Ramond, C Njapoum, V Duchatelle, C Degott, S Erlinger, B Rueff, D C Valla, F Degos.   

Abstract

A possible hepatotoxicity of cigarette smoke has been recently suggested by epidemiological and experimental studies. Our aim was to study the possible relationships between smoking and liver fibrosis and activity in patients with chronic hepatitis C. A cross-sectional study was performed in a group of 310 patients with chronic hepatitis C consecutively hospitalized for their first liver biopsy. The relationships between age, gender, alcohol consumption, route of contamination, tobacco consumption, and Knodell fibrosis and activity scores were examined in univariate, age-adjusted, and multivariate analyses. One hundred and seventy-six patients (57%) were current smokers. Smokers were younger (P <.001), more often of male gender (P =.001), more often alcohol consumers (P =.001), and more often had a history of intravenous drug use (P =.0001) than never smokers. Smoking was related to increased fibrosis and activity scores in age-adjusted (P =.009 and P =.005, respectively) and multivariate analyses (P =.03 and P =.04, respectively). Smoking increases the severity of hepatic lesions in patients with chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431742     DOI: 10.1053/jhep.2001.25385

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  45 in total

1.  Smoking and Liver Disease.

Authors:  Stephanie M Rutledge; Amon Asgharpour
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-12

Review 2.  Heavy smoking and liver.

Authors:  Abdel-Rahman El-Zayadi
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

3.  Association between serum cotinine level and prevalence of non-alcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey.

Authors:  Huafeng Shen; Jennifer L Peng; Sucharat Tayarachakul; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-09-15       Impact factor: 2.895

4.  Clearing the smoke in chronic liver diseases.

Authors:  Claudia O Zein
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

5.  Impact of smoking on histological liver lesions in chronic hepatitis C.

Authors:  C Hézode; I Lonjon; F Roudot-Thoraval; J-P Mavier; J-M Pawlotsky; E S Zafrani; D Dhumeaux
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

6.  Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy.

Authors:  L Dirven; N B Klarenbeek; M van den Broek; J H L M van Groenendael; P B J de Sonnaville; P J S M Kerstens; T W J Huizinga; B A C Dijkmans; W F Lems; C F Allaart
Journal:  Clin Rheumatol       Date:  2012-12-09       Impact factor: 2.980

7.  Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease.

Authors:  Shannon M Bailey; Sudheer K Mantena; Telisha Millender-Swain; Yavuz Cakir; Nirag C Jhala; David Chhieng; Kent E Pinkerton; Scott W Ballinger
Journal:  Free Radic Biol Med       Date:  2009-04-01       Impact factor: 7.376

Review 8.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

9.  Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.

Authors:  Valeria De Giorgi; Alessandro Monaco; Andrea Worchech; Marialina Tornesello; Francesco Izzo; Luigi Buonaguro; Francesco M Marincola; Ena Wang; Franco M Buonaguro
Journal:  J Transl Med       Date:  2009-10-12       Impact factor: 5.531

10.  Management of esophageal carcinoma associated with cirrhosis: a retrospective case-control analysis.

Authors:  Florence Trivin; Eveline Boucher; Elodie Vauléon; Isabelle Cumin; Elisabeth Le Prisé; Odile Audrain; Jean-Luc Raoul
Journal:  J Oncol       Date:  2009-12-22       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.